Pulmonary hypertension

Related records

Broader conditions (7)

• Arterial disorder
• Cardiovascular disorder
• Disease
• Disease by body system or component
• Human disease
• Hypertensive disorder
• Vascular disorder

Narrower conditions (18)

• Braddock syndrome
• Chronic thromboembolic pulmonary hypertension
• Drug- or toxin-induced pulmonary arterial hypertension
• Eisenmenger syndrome
• Heritable pulmonary arterial hypertension
• Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome
• Idiopathic pulmonary arterial hypertension
• Pulmonary arterial hypertension
• Pulmonary hypertension owing to lung disease and/or hypoxia
• Pulmonary hypertension, neonatal
• Pulmonary hypertension, primary, 1
• Pulmonary hypertension, primary, 2
• Pulmonary hypertension, primary, 3
• Pulmonary hypertension, primary, 4
• Pulmonary hypertension, primary, 5
• Pulmonary hypertension, primary, 6
• Pulmonary hypertension, primary, 7
• Pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis

Trials (996)

• [18F]FES PET/CT in PAH
• 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
• 129 Xenon Imaging in Patients Treated With Sotatercept
• 3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF
• 4D-flow Cardiac MRI to Assess Pulmonary Arterial Pressure in Pulmonary Hypertension
• A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients
• A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).
• A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.
• A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
• A Comparative Study of Three Modes of Ventilation During CPB in Pediatrics With Pulmonary Hypertension Undergoing Congenital Heart Surgeries
• A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
• A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
• A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis
• A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension
• A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
• A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)
• A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia
• A First-in-Human Study to Assess the Safety and Tolerability of PDNO
• A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234
• A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

Approved drugs (13)

• Ambrisentan
• Bosentan
• Iloprost
• Iloprost tromethamine
• Macitentan
• Nitric oxide
• Riociguat
• Selexipag
• Sildenafil citrate
• Sitaxentan sodium
• Tadalafil
• Treprostinil
• Treprostinil sodium

Drugs in development (40)

• Albuterol Phase 3
• Anakinra Phase 1
• Bardoxolone methyl Phase 3
• BQ-123 Phase 2
• Capsaicin Phase 2
• Carvedilol Phase 2
• Dapagliflozin Phase 1
• Dapagliflozin propanediol Phase 1
• Dexmedetomidine Phase 2
• Epoprostenol Phase 3
• Escitalopram Phase 3
• Esuberaprost potassium Phase 1
• Hydroxyurea Early phase 1
• Hymecromone Phase 2
• Imatinib Phase 3
• Imatinib mesylate Phase 3
• Levosimendan Phase 2
• Losartan Phase 3
• Milrinone Phase 2
• Nifedipine Phase 3

Other linked drugs (7)

• Epoprostenol sodium
• Frespaciguat
• Regadenoson
• Sotatercept
• Telaglenastat
• Tolazoline
• Treprostinil diolamine